Clinical Trials Sponsored by Mayo Clinic

Total 19481 results

Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA Melanoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers

Unspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Single-Photon Emission Computed Tomography, Computed Tomography Lymphoscintigraphy, and Intensity-Modulated Radiation Therapy in Treating Patients Who Have Undergone Surgery for Stage I or Stage II Breast Cancer

Breast Cancer | Lymphedema

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Metastatic Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain

Pain | Multiple Myeloma and Plasma Cell Neoplasm

United States
Mark Stegall
Alexion Pharmaceuticals

Completed

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant

Kidney Transplant

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer

Breast Cancer
Horng Chen
FlowMedica, Inc.

Terminated

Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure

Cardiorenal Syndrome

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Head and Neck Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

Duct Cell Adenocarcinoma of the Pancreas | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
Abimbola Famuyide
Hologic, Inc.

Completed

Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia (iTOM)

Menorrhagia

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Unspecified Adult Solid Tumor, Protocol Specific | Localized Gallbladder Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma of the Gallbladder

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery

Hepatic Complication

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Cathartic-Free DECT Colonography for Detection of Colonic Polyps

Colonic Polyps

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Prostate Cancer

United States
Lauren M. F. Syrowik

Completed

Use of a Collagen Membrane for Soft Tissue Grafting

Localized Gingival Recession

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Anorexia | Weight Changes

United States
Mayo Clinic
Qatar National Research Fund

Completed

Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome

Acute Coronary Syndrome

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vibro-Acoustography Imaging in Diagnosing Breast Masses in Women With a Breast Mass or Breast Cancer

Breast Cancer

United States
Margaret L. Dow, M.D.

Completed

A Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure

Surgical Wound

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

Leukemia | Chronic Myeloproliferative Disorders

United States
Mayo Clinic
Yukon Kuskokwim Health Corporation

Completed

Tobacco Cessation Treatment for Alaska Native Youth

Tobacco Cessation

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women

Breast Cancer

United States
Mayo Clinic
Eli Lilly and Company

Completed

An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

Depression

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia

Leukemia

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer

United States
Mayo Clinic
Novo Nordisk A/S

Completed

Using Networks, Informatics, Technology, and Education in Care for People With Diabetes

Diabetes Mellitus

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative Disorder

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States, Canada
Mayo Clinic
National Cancer Institute (NCI)

Completed

Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma

Sarcoma
Mayo Clinic
National Cancer Institute (NCI)

Completed

High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse

Multiple Myeloma and Plasma Cell Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Exisulind Prior to Radical Prostatectomy

Prostatic Neoplasms

United States
Mayo Clinic
National Cancer Institute (NCI)

Not yet recruiting

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Adenocarcinoma

United States
Mayo Clinic
Arizona State University (ASU)

Not yet recruiting

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

Obstructive Sleep Apnea

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters

Thyroid Gland Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Metastatic Melanoma | Stage III Lung Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Locally Advanced Malignant Solid Neoplasm | Locally Advanced Melanoma | Metastatic Malignant Solid Neoplasm | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma... and other conditions

United States
Well Living Lab, Inc.
Mayo Clinic

Recruiting

Determining How Indoor Lighting Affects the Brain Health of Older Adults

Physical Activity | Sleep | Cognitive Function | Social Isolation

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Early Stage Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Not yet recruiting

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Malignant Central Nervous System Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

Breast Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

Soft Tissue Sarcoma | Recurrent Soft Tissue Sarcoma | Resectable Soft Tissue Sarcoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Breast Carcinoma | Breast Fibrocystic Change | Benign Breast Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer

Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8

United States
Peter C. Amadio, M.D.

Recruiting

A Study of Fisetin to Treat Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

United States

Clinical Trials Sponsored by Mayo Clinic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations